Telfast Oral Suspension 6 mg/ml
Product details
Registration number: SIN14199P
Classification: Prescription Only
Active ingredients: Fexofenadine 28 mg/5 ml eqv Fexofenadine hydrochloride
Strength: 30.00 mg/5 ml
Dosage form: SUSPENSION
Route: ORAL
Registrant: OPELLA HEALTHCARE SINGAPORE PTE. LTD.
ATC code: R06AX26
HSA approval date: 20 July 2012
Manufacturer(s): SANOFI MEDLEY FARMACÊUTICA LTDA.
Manufacturing country/countries: BRAZIL
What are the HSA registration number and classification for Telfast Oral Suspension 6 mg/ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14199P
Classification: Prescription Only
What active ingredients and strength are recorded for Telfast Oral Suspension 6 mg/ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Fexofenadine 28 mg/5 ml eqv Fexofenadine hydrochloride
Strength: 30.00 mg/5 ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Telfast Oral Suspension 6 mg/ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: SUSPENSION
Route: ORAL
Who is the recorded registrant for Telfast Oral Suspension 6 mg/ml?
According to the HSA dataset updated 7 August 2026:
Registrant: OPELLA HEALTHCARE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for Telfast Oral Suspension 6 mg/ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): SANOFI MEDLEY FARMACÊUTICA LTDA.
Manufacturing country/countries: BRAZIL
Where can I look up Telfast Oral Suspension 6 mg/ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14199P or the exact product name Telfast Oral Suspension 6 mg/ml. The general register link does not preselect this product.
What are the source dates for this Telfast Oral Suspension 6 mg/ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Telfast Oral Suspension 6 mg/ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14199P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)